| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Topotecan | FIMM | pan-cancer | AAC | 0.017 | 0.9 |
| mRNA | avrainvillamide | CTRPv2 | pan-cancer | AAC | 0.0053 | 0.9 |
| mRNA | CI-976 | CTRPv2 | pan-cancer | AAC | -0.0051 | 0.9 |
| mRNA | BRD-K20514654 | CTRPv2 | pan-cancer | AAC | -0.0067 | 0.9 |
| mRNA | BRD-K51490254 | CTRPv2 | pan-cancer | AAC | 0.0047 | 0.9 |
| mRNA | Compound 1541A | CTRPv2 | pan-cancer | AAC | -0.0048 | 0.9 |
| mRNA | epigallocatechin-3-monogallate | CTRPv2 | pan-cancer | AAC | -0.0044 | 0.9 |
| mRNA | PD-0325901 | gCSI | pan-cancer | AAC | 0.0071 | 0.9 |
| mRNA | LE-135 | CTRPv2 | pan-cancer | AAC | 0.0044 | 0.9 |
| mRNA | CIL55 | CTRPv2 | pan-cancer | AAC | -0.0071 | 0.9 |